One trading day after announcing the news that the huge hedge fund he runs, Pershing Square Capital Management, had partnered with Valeant Pharmaceuticals International to make an unsolicited $45.6 billion cash and stock takeover bid for Allergan, ...
Ackman: Drug Industry Ripe for Cost Cuts
Allergan adopts 'poison pill' defense in Valeant takeover bid
Los Angeles Times
Related articles »